World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
17394
World Ranking
17826
National Ranking
339

Overview

Vega Masignani is affiliated with Novartis in Switzerland and has contributed extensively to the fields of medicine, immunology, and microbiology. Their research focuses on bacterial infections and vaccines, with significant work also conducted on influenza virus studies and pneumonia or respiratory infections.

Masignani's recent publications include studies on meningococcal vaccines and bacterial adhesion mechanisms. Key papers include:

  • "Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity" (2020, Nature Communications)
  • "Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines" (2022, mSphere)
  • "4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp" (2020, PLoS Pathogens)
  • "Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion" (2024, mBio)
  • "Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine" (2025, mSphere)

The scientist regularly publishes in journals including mSphere, Nature Communications, PLoS Pathogens, mBio, and npj Vaccines.

Frequent collaborators in Masignani's work include Mariagrazia Pizza, Rino Rappuoli, Domenico Maione, Werner Pansegrau, and Erika Bartolini, reflecting a network of co-researchers focusing predominantly on microbial pathogenesis and vaccine development.

Masignani's research spans several subfields, notably:

  • Microbiology
  • Epidemiology
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging
  • Immunology

Their main research topics cover:

  • Bacterial Infections and Vaccines
  • Influenza Virus Research Studies
  • Pneumonia and Respiratory Infections
  • Monoclonal and Polyclonal Antibodies Research
  • Biochemical and Structural Characterization
  • Complement system in diseases
  • Escherichia coli research studies

In addition to articles, Masignani has contributed to book publications, including a 2022 title published by Frontiers Media titled "Le coronavirus et ces microbes qu'il nous faut combattre, première édition."

Best Publications

  • Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial “pan-genome”

    Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Claudio Donati

  • Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

    M Pizza;[No Value] Scarlato;[No Value] Masignani;MM Giuliani

  • The microbial pan-genome

    Duccio Medini;Claudio Donati;Hervé Tettelin;Vega Masignani

  • Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

    Hervé Tettelin;Nigel J. Saunders;John Heidelberg;Alex C. Jeffries

  • A universal vaccine for serogroup B meningococcus

    Marzia M. Giuliani;Jeannette Adu-Bobie;Maurizio Comanducci;Beatrice Aricò

  • Identification of a universal Group B streptococcus vaccine by multiple genome screen.

    Domenico Maione;Immaculada Margarit;Cira D. Rinaudo;Vega Masignani

  • SARS — beginning to understand a new virus

    Konrad Stadler;Vega Masignani;Markus Eickmann;Stephan Becker

  • Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae

    Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Jonathan A. Eisen;Jonathan A. Eisen

  • A pneumococcal pilus influences virulence and host inflammatory responses

    M A Barocchi;J Ries;X Zogaj;C Hemsley

  • NadA, a Novel Vaccine Candidate of Neisseria meningitidis

    Maurizio Comanducci;Stefania Bambini;Brunella Brunelli;Jeannette Adu-Bobie

  • Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870

    Vega Masignani;Maurizio Comanducci;Marzia Monica Giuliani;Stefania Bambini

  • Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species

    Claudio Donati;N. Luisa Hiller;Hervé Tettelin;Alessandro Muzzi

  • Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells

    Barbara Capecchi;Jeannette Adu-Bobie;Federica Di Marcello;Laura Ciucchi

  • A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells

    Fabio Bagnoli;Monica Moschioni;Claudio Donati;Valentina Dimitrovska

  • Streptococcus pneumoniae Pilus Subunits Protect Mice against Lethal Challenge

    Claudia Gianfaldoni;Stefano Censini;Markus Hilleringmann;Monica Moschioni

  • Reverse vaccinology: a genome-based approach for vaccine development.

    Vega Masignani;Rino Rappuoli;Mariagrazia Pizza

  • Staphylococcus aureus protein and nucleic acid encoding the same

    Vega Masignani;Marirosa Mora;Maria Scarselli;マリア スカーセリ

  • The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies

    Marzia Monica Giuliani;Laura Santini;Brunella Brunelli;Alessia Biolchi

  • Pneumococcal Pili Are Composed of Protofilaments Exposing Adhesive Clusters of Rrg A

    Markus Hilleringmann;Fabiola Giusti;Barbara C. Baudner;Vega Masignani

  • Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen

    Enrico Malito;Agnese Faleri;Paola Lo Surdo;Daniele Veggi

Frequent Co-Authors

Rino Rappuoli
Rino Rappuoli Imperial College London
Mariagrazia Pizza
Mariagrazia Pizza Imperial College London
Maurizio Comanducci
Maurizio Comanducci Novartis (Switzerland)
Hervé Tettelin
Hervé Tettelin University of Maryland, Baltimore
Guido Grandi
Guido Grandi University of Trento
Marzia Monica Giuliani
Marzia Monica Giuliani GlaxoSmithKline (Italy)
Antonello Covacci
Antonello Covacci Novartis (Switzerland)
John J. Donnelly
John J. Donnelly Novartis (United States)
Nicholas M. Valiante
Nicholas M. Valiante Novartis (Switzerland)
Claire M. Fraser
Claire M. Fraser University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Vega Masignani

Trending Scientists